Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lou Silverman Insider Profile
4 Followers
Lou Silverman, Director at Staar Surgical, holds 31.27K shares in OncoCyte (Ticker: OCX), holds 4.42K shares in Staar Surgical (Ticker: STAA), holds 76.90K shares in NextGen Healthcare (Ticker: NXGN).
Lou Silverman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Lou Silverman
Lou Silverman's Trading History
Staar Surgical
Aug 12, 2021
Director
Uninformative Sell
4.36M
$207.75K
OncoCyte
Jun 27, 2023
Director
Uninformative Buy
―
$77.55K
NextGen Healthcare
―
―
―
$1.84M
Questcor
Apr 09, 2014
―
Uninformative Sell
845.70K
―
List of latest transactions for each holding click on a transaction to see Lou Silverman's performance on stock
You May Also Like
Lou Silverman insider profile FAQ
What is the percentage of profitable transactions made by Lou Silverman?
The percentage of profitable transactions made by Lou Silverman is ―.
What is the average return per transaction made by Lou Silverman?
The average return per transaction made by Lou Silverman is ―.
What stocks does Lou Silverman hold?
Lou Silverman holds: STAA, OCX, NXGN, QCOR stocks.
What was Lou Silverman’s latest transaction?
Lou Silverman latest transaction was an Uninformative Buy of ―.
What was Lou Silverman's most profitable transaction?
Lou Silverman’s most profitable transaction was an Informative Buy of STAA stock on August 11, 2015. The return on the trade was 5.20%.
What is Lou Silverman's role in Staar Surgical?
Lou Silverman's role in Staar Surgical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.